This week, the European Central Bank’s (ECB) interest rate decision will take centre stage. The bank is expected to continue reducing its benchmark policy rates amid mounting economic risks linked to tariffs. In Asia, China’s GDP will be closely watched by investors.
Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as both the US and Europe heavily rely on each other.